Growth Capitalist (https://growthcapitalist.com/tag/reg-a/page/5/)
The selling broker for Med-X’s Regulation A+ offering has quit, citing the late filing of the company’s 2015 annual report, which resulted in the suspension of the offering by the Securities and Exchange Commission in September.
SEC’s Division of Corporation Finance has issued four new compliance and disclosure interpretations (“C&DIs”) addressing aspects of offerings under Regulation A and Regulation D.
The Securities and Exchange Commission held its annual open meeting on November 17 seeking feedback from dealmakers in the emerging growth finance market on the impact of newly enacted reforms to Regulation A on capital formation by small businesses.
